drugset / Trial / NCT00666653
Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether there is a benefit to giving a dopamine agonist to a patient with Parkinson's disease who is already being treated with levodopa.
Timeline
- Start
- 2003-07
- Primary completion
- 2007-05
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pramipexole | Unknown | 1 mg | Oral |